Economics :: Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)

Last Posted: Jan-27-2017 8AM

 Economics expanded expanded

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
Z Stark et al, Genetics in Medicine, January 26, 2017

Health economics, genomics and the value of knowing
J Buchanan, January 5, 2016

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.
Mitchell Dominic et al. Molecular diagnosis & therapy 2016 Oct

More information on this topic

Last Posted: Jan 26, 2017

---

• Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
  Z Stark et al, Genetics in Medicine, January 26, 2017
• Health economics, genomics and the value of knowing
  J Buchanan, January 5, 2016
• Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia.
  de Graaff Barbara et al. Applied health economics and health policy 2016 Dec
• Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapy.
  Glueck Charles J et al. Lipids in health and disease 2016 Mar 1555
• Colon cancer runs in my family: Should I get a genetic test? I worry that'll affect my insurance.
   et al. Consumer reports 2017 82(1) 21
• Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany.
  Schremser Katharina et al. PharmacoEconomics 2015 Nov 33(11) 1215-28
• US Cancer Moonshot must strike a balance between research and prevention.
   et al. Nature 2016 Nov 539(7630) 467
• Using needs-based frameworks for evaluating new technologies: an application to genetic tests.
  Rogowski Wolf H et al. Health policy (Amsterdam, Netherlands) 2015 Feb 119(2) 147-55
• Value judgments for priority setting criteria in genetic testing: a discrete choice experiment.
  Severin Franziska et al. Health policy (Amsterdam, Netherlands) 2015 Feb 119(2) 164-73
• Clinical integration of next generation sequencing: coverage and reimbursement challenges.
  Deverka Patricia A et al. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2014 42 Suppl 122-41
• A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers.
  Oosterhoff Marije et al. Applied health economics and health policy 2016 Feb 14(1) 51-65
• Challenges in the health economics of familial hypercholesterolemia.
  Norman Richard et al. Current opinion in lipidology 2016 Oct
• Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.
  Mitchell Dominic et al. Molecular diagnosis & therapy 2016 Oct
• Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
  van Nimwegen Kirsten J M et al. Clinical chemistry 2016 Nov 62(11) 1458-1464
• Progress lies in precision.
  Desmond-Hellmann Sue et al. Science (New York, N.Y.) 2016 Aug 353(6301) 731
• Big Data, Big Research: Implementing Population Health-Based Research Models and Integrating Care to Reduce Cost and Improve Outcomes.
  Anoushiravani Afshin A et al. The Orthopedic clinics of North America 2016 Oct 47(4) 717-24

more